{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-005890","form_type":"8-K","ticker":"AGPU","cik":"0001446159","company_name":"Axe Compute Inc.","filed_at":"2025-09-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.009142+00:00","generated_at":"2026-05-17T06:44:06.873300+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Predictive Oncology grants 124,959 RSUs to CEO and 97,000 RSUs to Interim CFO","bullets":["CEO Raymond F. Vennare receives 124,959 RSUs; Interim CFO Josh Blacher receives 97,000 RSUs.","RSUs vest fully on October 31, 2025, subject to continued service through that date.","Grants made under the 2024 Equity Incentive Plan; form of award agreement filed as Exhibit 10.1.","Each RSU represents the right to receive one share of common stock upon vesting."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-005890","json":"https://secwatch.observer/filing/0001171843-25-005890.json","markdown":"https://secwatch.observer/filing/0001171843-25-005890.md","text":"https://secwatch.observer/filing/0001171843-25-005890.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1446159/000117184325005890/0001171843-25-005890-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1446159/000117184325005890/f8k_090925.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:44:06.873300+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}